Novare Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$26.5M |
| 2 |
SHPG
Shire pic
SHPG
|
+$7.08M |
| 3 |
DuPont de Nemours
DD
|
+$6.75M |
| 4 |
KeyCorp
KEY
|
+$5.75M |
| 5 |
Microsoft
MSFT
|
+$4.92M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$7.08M |
| 2 |
DD
Du Pont De Nemours E I
DD
|
+$6.04M |
| 3 |
Truist Financial
TFC
|
+$5.89M |
| 4 |
Wells Fargo
WFC
|
+$4.46M |
| 5 |
Automatic Data Processing
ADP
|
+$4.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.61% |
| 2 | Healthcare | 13.54% |
| 3 | Energy | 12.06% |
| 4 | Industrials | 9.36% |
| 5 | Technology | 8.83% |
Similar funds
Novare Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, Novare Capital Management held 161 positions worth $568M, up 28% from $444M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Novare Capital Management deployed $137M of net new capital in Q3 2017, opening 38 new positions and adding to 60 existing holdings. Its largest new stake was Berkshire Hathaway Class A: 100 shares worth $275K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Energy.
On the sell side, the largest reduction was Truist Financial, an estimated $5.89M trimmed.
- Novare Capital Management's largest Q3 2017 buy was Berkshire Hathaway Class A: 100 shares worth $275K.
- Novare Capital Management added most to Microsoft in Q3 2017, an estimated $4.92M increase.
- Novare Capital Management's biggest Q3 2017 reduction was Truist Financial, cutting an estimated $5.89M.
- Novare Capital Management fully exited Pfizer in Q3 2017, selling an estimated $7.08M.
- Novare Capital Management's ten largest holdings make up 22% of its $568M portfolio in Q3 2017.
- Novare Capital Management opened 38 new positions and closed 9 in Q3 2017.
- Novare Capital Management's portfolio value rose 28% quarter-over-quarter to $568M.
Based on Novare Capital Management's 13F filing for Q3 2017, filed 7 Nov 2017.